Authors
A Luger, L H A Broersen, N R Biermasz, B M K Biller, M Buchfelder, P Chanson, J O L Jorgensen, F Kelestimur, S Llahana, D Maiter, G Mintziori, F Petraglia, R Verkauskiene, S M Webb, O M Dekkers
Developed By:
The European Society of Endocrinology, including representatives from: The Endocrine Society, European Society for Paediatric Endocrinology (ESPE), European NeuroEndocrine Association (ENEA) and European Reference Network on Rare Endocrine Conditions (Endo-ERN)
Endorsed by The Endocrine Society
Introduction
This guideline was developed for health care providers who may see pregnant patients with pituitary adenomas. In general, these women (with the exception of those with small nonfunctioning adenomas and microprolactinomas) should preferably be managed by a multidisciplinary team in expert pituitary centers, including Pituitary Tumor Centers of Excellence (PTCOE)/Endo-ERN Reference Centers and their affiliated regional healthcare providers. The purpose of this guideline is to provide clinicians with practical guidance for the management of patients with a pituitary adenoma during pregnancy or considering pregnancy.
Related Resources
A number of additional resources were also made available.